e-learning
resources
Barcelona 2010
Monday, 20.09.2010
New mechanisms in lung development, acute and chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2010 Abstract: Possible effect of
GSTM1
and
GSTT1
polymorphisms on the risk for development of COPD and total antioxidant plasma capacity
D. Dimov, T. Vlaykova, S. Emin, K. Yordanova, V. Ilieva, A. Koychev, G. Prakova (Bulgaria)
Source:
Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Session:
New mechanisms in lung development, acute and chronic lung diseases
Session type:
E-Communication Session
Number:
2197
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Dimov, T. Vlaykova, S. Emin, K. Yordanova, V. Ilieva, A. Koychev, G. Prakova (Bulgaria). LSC 2010 Abstract: Possible effect of
GSTM1
and
GSTT1
polymorphisms on the risk for development of COPD and total antioxidant plasma capacity. Eur Respir J 2010; 36: Suppl. 54, 2197
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
LSC 2010 Abstract: Influence of mutations and COPD clinical features on
SERPINA1
phenotypic expression
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
LSC 2010 Abstract: TNFα promoter polymorphism is associated with increased local production and enhanced downstream inflammation in COPD
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Role of
-511C>T/+3953C>T
haplotypes of
IL1B
gene as risk factors of COPD
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
The role of
E-cadherin
polymorphisms in the annual FEV
1
decline in asthma
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009
IL1RL1
polymorphisms are associated with the level of soluble
IL1RL1
and asthma development in children
Source: Annual Congress 2009 - Asthma genetics: from genome wide to single nucleotide polymorphisms
Year: 2009
Imbalances in TNFα in patients with a TNFα polymorphism and a COPD phenotype
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
LSC 2010 Abstract: Functional variant of the
ANXA11
gene: True marker of protection and candidate disease modifier in sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
Role of -511C>T and +3953C>T SNPs of
IL1B
gene as risk factors of COPD and bronchial asthma in Bulgarian population
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011
"Loss of function" variants of the
P2RX7
gene in Czech patients with sarcoidosis: A genetic association study
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
LSC 2011 Abstract: Suppression of antitumor immunity as a potential link between inflammation and cancer in COPD
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Intermediate and severe α
1
-antitrypsin deficiency: influence on plasma α
1
-antitrypsin, FEV
1
and risk of COPD. Three meta-anlyses
Source: Eur Respir J 2002; 20: Suppl. 38, 513s
Year: 2002
Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
LSC 2011 Abstract: The relationship of CD4+/CD8+ ratios and toll like receptor-2 expression with COPD and smoking
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
The effect of reverse causation (RC) and confounding-by-indication (CbI) on the association between infant antibiotic use and asthma risk – A systematic review and meta-analysis
Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma
Year: 2010
nos1
and
nos2a
genetic variants modify the association between smoking and FE
NO
level in non-asthmatics from the EGEA study
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
Interferon-γ
gene polymorphisms on interferon-γ production affects susceptibility and treatment response to tuberculosis in Japanese population
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
The influence of TNFα gene polymorphism on the therapeutic response in patients with sarcoidosis
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort.
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept